Liana Hennum
Liana Hennum publishes mostly in Molecular Biology, Cardiology and Cardiovascular Medicine and Nephrology, on topics such as Amyloidosis: Diagnosis, Treatment, Outcomes, Parathyroid Disorders and Treatments and Neurological disorders and treatments.
- World rank
- #4,116,880 of 7,710,434 ranked researchers
- Rank in United States
- #1,116,360 of 1,627,098
- Works
- 17
- Citations
- 5
- Citations per work
- 0.3
What does Liana Hennum research?
Liana Hennum's work is mostly in Medicine (58%), Biochemistry, Genetics and Molecular Biology (28%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1058.2%
- Medicine1058.2%
- Life Sciences527.9%
- Everything else213.9%
- 1Molecular Biology28% of their works
- 2Cardiology and Cardiovascular Medicine19% of their works
- 3Nephrology16% of their works
- 4Neurology12% of their works
- 5Endocrinology, Diabetes and Metabolism7% of their works
- 6Genetics5% of their works
Research topics
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Parathyroid Disorders and Treatments
- Neurological disorders and treatments
- Cardiac pacing and defibrillation studies
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Intracerebral and Subarachnoid Hemorrhage Research
- Dermatological and Skeletal Disorders
- Chemical Reactions and Isotopes
Which keywords describe Liana Hennum's research?
The keywords of their largest research topics: Cardiac Amyloidosis, Transthyretin, FGF23, phosphate, Deep Brain Stimulation, Parkinson's Disease, Cardiac Resynchronization Therapy and Cerebral Amyloid Angiopathy.
- Pseudoxanthoma Elasticum
- Deuterium
- Kinin Receptor Family
- Implantable Cardioverter-Defibrillator
- Cerebral Amyloid Angiopathy
- Parkinson's Disease
- phosphate
- Transthyretin
- Cardiac Amyloidosis
- FGF23
- Deep Brain Stimulation
- Cardiac Resynchronization Therapy
- Hereditary Angioedema
- Intracerebral Hemorrhage
- Arterial Calcification
- Drug Discovery
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 16 words, with their numbers
- Cardiac Amyloidosis121 topic
- Transthyretin121 topic
- FGF2371 topic
- phosphate71 topic
- Deep Brain Stimulation31 topic
- Parkinson's Disease31 topic
- Cardiac Resynchronization Therapy21 topic
- Cerebral Amyloid Angiopathy21 topic
- Hereditary Angioedema21 topic
- Implantable Cardioverter-Defibrillator21 topic
- Intracerebral Hemorrhage21 topic
- Kinin Receptor Family21 topic
- Arterial Calcification11 topic
- Deuterium11 topic
- Drug Discovery11 topic
- Pseudoxanthoma Elasticum11 topic
Where does Liana Hennum work?
Liana Hennum's main affiliation in the publication record is Bridge Pharma (United States), United States.
How many publications and citations does Liana Hennum have?
OpenAlex counts 17 works and 5 citations for Liana Hennum, an h-index of 1, ranking #4,116,880 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Liana Hennum. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.